GNA14和GNAQ的体性突变会导致脊柱和内外轴性洞穴性血管瘤
Jian Ren1, Ziwei Cui1, Chendan Jiang1
1Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, China International Neuroscience Institute, National Center for Neurological Disorders, Beijing, China.
American journal of human genetics
|June 25, 2024
概括
在GNA14,GNAQ和GJA4中发生的基因突变驱动了额外轴性洞穴性血管瘤 (ECHs). 针对这些途径的拉巴胺在患者身上显示出有前途的结果,为治疗这些复杂的血管病变提供了新的希望.
科学领域:
- 血管生物学 血管生物学
- 人类遗传学 人类遗传学
- 在瘤学瘤学.
背景情况:
- 额外轴腔性血管瘤 (ECHs) 是一种罕见的,高风险的血管形.
- 遗传驱动因素和ECH的有效治疗方法在很大程度上是未知的.
- 对于ECHs的现有疗法具有有限的疗效和重大风险.
研究的目的:
- 为了确定ECHs的遗传基础.
- 阐明受ECH相关突变影响的分子通路.
- 探索针对ECHs的有针对性的治疗策略.
主要方法:
- 31个ECH组织样本的全外体和有针对性的深度测序.
- 在体外和体外功能研究,包括转录组分析.
- 鼠标异种移植模型和拉帕治疗的案例研究.
主要成果:
- 在77.4%的ECH样本中,GNA14,GNAQ或GJA4的体质误解变异被确定.
- GNAQ突变激活了PI3K-AKT-mTOR和血管生成途径.
- GNA14突变激活了MAPK和血管生成途径.
- 拉帕米辛治疗导致皮肤血管瘤的回归,并改善了GNAQ突变患者的运动功能.
结论:
- GNA14,GNAQ和GJA4突变是ECH发展的关键驱动因素.
- 特定的突变激活了不同的瘤原和亲血管原信号通路.
- 用拉巴胺进行向治疗显示出治疗ECH的潜力,特别是那些由GNAQ突变驱动的.
关键词:
在 GJA4 中,GJA4 是在 GNA14 中,GNA14 是这是GNAQQ.洞穴性形是一种形.内皮细胞是内皮细胞.这种类型的血瘤 (hemangiomas) 是这种药物是拉帕米辛 (Rapamycin).身体突变是一种体质突变.血管异常是一种血管异常.血管形 血管形 血管形更多相关视频
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
15.8K
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
1.9K
相关概念视频
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity: